-
17873612(pyruvate kinase): Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer.
Immunochemical fecal occult blood test (FOBT) and determination of tumor pyruvate kinase isoenzyme type M2 (TuM2-PK) in stool samples may be valuable new screening tools for colorectal cancer (CRC).
-
12820312(Pyruvate Kinase): Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls.
The determination of Tumor M2 Pyruvate Kinase (Tumor M2-PK) in EDTA plasma has been described as a tumor marker in a variety of different tumor types.
-
15162541(Pyruvate Kinase): Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls.
To achieve this , tumor cells generally overexpress a special glycolytic isoenzyme , termed pyruvate kinase type M (2).
-
2971267(Pyruvate Kinase): Heterogeneity of glycolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer.
Heterogeneity also existed in isozyme composition of pyruvate kinase.
-
178389(Pyruvate Kinase): [Pyruvate kinase activity in the liver of rats with induced tumors].
M-isozyme pyruvate kinase activity proved to be elevated in the liver of rats with hepatoma induced by p-dimethylaminoazobenzene.
-
15962369(glutamine): Glutamine is highly effective in preventing in vivo cobalt-induced oxidative stress in rat liver.
To evaluate the in vivo effect of glutamine on cobalt-generated oxidative stress and (HO-1) induction in rat liver.